The binding properties of prostaglandin PGE and ACTH, and their action on adenylate cyclase activity (AC) have studied in 12 hormone producing tumors of the human adrenal cortex and compared with those found in the same type of subcellular preparation (20 000 xg) from normal human adrenal glands.
A specific binding of PGE and a stimulation of AC by this hor~pge and by NaF was obtained in all cases. A specific binding of I-ACTH was also observed in all cases, but ACTH only stimulated AC in six cases. In the other six cases where AC was insensitive to ACTH, the steroidogenesis was not stimulated " i~~y i v o " by this hormo However these tumors bound specifically l -T'5 1 -ACT" the K being similar for both peptides ACTH1-?4 bu andtimes 1owe!'~6$A the o4e found in normal adrenal cortex for 'EgI-ACTHI-24. This results strongly suggests the possibility of a modificat~on or a loss of the receptor site.which binds the N-terminal sequence (1-10) of ACTH known as the biologically active part of the molecule. The nean values of the quotient increase of 1;-GB-P: increase of cortisol of norndls and hetcrocyyot?~ are also statistically different on the l i G , 0 0 1 level. 2 2 out of j0 values of heterocygotes are higher than the highest value of normals. Thils for the present we are able to distingiiish about ;C> of heterocygotes from the norcais. Supported by Detitsche Forschungsgeneinschaft SFB j l /~
J.M. ~j n a r , F. ~ayar$*and I?. These parameters were determined in 34 children and adolescents with C-21 AH, during 2 years period. Blood samples were obtained between 6 and 9 a.m. on fasting individuals after one night of rest at the hospital. Elevated levels of T were observed before treatment or when the glucocorticoid doses were in sufficient. In some cases, starting or raising the mineralocorticoid treatment (9 alpha fluorocortisol) was followed by a decrease in T levels.
High levels of R. A. were constantly found before treatment, even in the absence of salt losing syndrome. In some cases treated by glucocorticoid and salt, R.A. levels remained elevated: appropriated doses of 9 alpha fluorocortisol,induced a marked decrease in R.A. levels. Elevated1 17-OH levels were always present before treatment, but frequently failed to normalize under therapy. Important individual variations were ibserved from day today and in the same day. As far as ACTH is concerned, our data are too inconsistnet to take into account this parameter. Regular determinations of plasma T and R . A. allow us a better control of glucocorticoid therapy (our mean dose being 19 mg hydrocortisone/m2/day which is lower than dosages usually published) and of skeletal maturation (however, none of this infants followed since birth are older than two years). simpled between 8 and 10 a.m;, durina a normal sodium intake had a mean PA value of 20.6 -2.4 (SEM) pg/ml (basal levels).
!The increase in PA after IM injection o f~l -2 4 ACTH (250 pg) waa 500 to 2000 % (9 subjects) and after five days of,lor sodium intake (LSI) it was 457 to 1220 % (5 subjects). In 12 infants aged 1 to 12 months, the mean basal PA was 102 pg/ml (range 19 to 171 pg/ml). Among the 2 0 children with congenital adrenal hyperplasla, 4 salt loosers were studied before any treatment during the first month of life, while they were suffering from sn acute salt depletion. Their PA were lower than 50 pg/ml. Sixteen 2 to 9 year old patients never had clinical symptoms of salt depletion. While 8 of these
were not under treatment, basal PA were elevated (40 to 320 pg/ml). The LSI and the ACTH injection induced variable but limlted increases in PA. Since the biosynthesis of Aldosterone appears to be limited, these patients may be considered potential salt loosers. When treated with cortisol, the PA levels decreased and a positive correlation ( pd0.001) between PA and 17 Hydroxyprogesterone, levels was observed. In 13 of the 17 children with Addison's Disease, PA was lower than 15 ~~/ m l . Four other ~atients exhibited normal basal Plasma DHEA and T were measured after column separation by radioimmunoassay, in 125 normal boys aged 5 to 16 years ; bone age. (BA) was from 4 to 16 years.DHEA rose from 48.1 2 1.6 (mean 2 SE) at BA 6 years. to 132 f 19 ng/lOO ml .at BA 9 years. A further increase was observed at SA 13 years to 316. f 13 ng/lOO ml, contemporary of increase of T fro01 13 2 1.8 to 24.6 ng/lOO ml, with a steady rise of T to 520 2 135 ng/lOO ml at BA 15 years.
In 96 normal girls asqd 6 to 16 years (BA from 4 to 16 ears), DHEA rose from 31.9 -38 (BA 5 ears) to 64 ' 8.6 at BA 6 years, then to 123 ' 47 at BA 10 years. At BA 13 years, mean DHEA was 492 f 84 ng/100 ml. This last increase was cgntemporary of T increase from 18 2 3.3 (BA 10 years) to 33 -4 (BA 13 years). In Addison's disease, very low levels of DHEA were found although pubertal development hatl started. In 6 girls with treated congenital virilizing adrenal hyperplasia, normal to high levels of DHEA and T were observed. In 2 cases with Cushing's syndrome, very high lev,els of DHEA decreased with therapy to normal or low levels.
-.-levels and the increases in PA during LSI were 300 to 1100 %, kith normal sodium balances. A deficiency progressively affecting diverse adrenocortical functions is discussed.
